Skip to main content
Clinical Trials/NCT02539394
NCT02539394
Completed
Not Applicable

Do Intraoperative Topical Corticosteroids Aid in the Prevention of Postoperative Dysphagia Following Elective Anterior Cervical Discectomy and Fusion? A Randomized, Controlled, Double Blinded Clinical Trial

Hospital for Special Surgery, New York0 sites128 target enrollmentAugust 2015

Overview

Phase
Not Applicable
Intervention
Methylprednisolone Acetate
Conditions
Cervical Disc Herniation
Sponsor
Hospital for Special Surgery, New York
Enrollment
128
Primary Endpoint
Degree of Dysphagia Patients Experience (Social)
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The purpose of this study is to determine what effect intraoperative topical steroids have on reducing swallowing difficulty following Anterior Cervical Discectomy and Fusion surgery.

Detailed Description

Background: Dysphagia is a serious post-operative concern in patients following anterior cervical surgery. Although many experts have acknowledged that dysphagia is often incompletely understood and defined, there is a significant amount of literature to support the significance of this clinical entity. This is the first randomized study to examine the use of topical steroids for the prevention of dysphagia postoperatively after anterior cervical discectomy and fusion. Study Design: This study is a single site, double blinded randomized control trial. All individuals undergoing 2-4 level ACDF that meet the inclusion criteria will be randomized to either: 1. treatment arm or 2. control arm. Both arms will undergo their planned surgeries and will receive the exact same procedure and standard of care as if they were not enrolled in a study. The only difference is that the treatment arm will receive 40 mg of Methylprednisolone Acetate delivered with one Hemostatic Matrix Kit injectable delivery vehicle prior to closure in the prevertebral soft tissues. The control group will receive only Hemostatic Matrix Kit prior to closure in the prevertebral soft tissues. Outcomes: Patients will be asked to fill out questionnaires that assess dysphagia, general swallowing difficulty, and how neck pain impacts their quality of life. Additionally Radiographic images will be obtained at set time points to evaluate soft tissue inflammation and bony fusion.

Registry
clinicaltrials.gov
Start Date
August 2015
End Date
November 12, 2021
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Hospital for Special Surgery, New York
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Any patient \> 18 years undergoing a 2-4 level Anterior Cervical Discectomy and Fusion

Exclusion Criteria

  • Patients undergoing revision surgery
  • Pediatric patients
  • Trauma patients with cervical spine fractures
  • Patients with cancer
  • Patients with active infection
  • Patients with a known allergy to Methylprednisolone Acetate
  • Patients who refuse to participate
  • Non English speakers

Arms & Interventions

Treatment

Procedure: Anterior Cervical Discectomy and Fusion. The treatment arm will receive 40 mg of Methylprednisolone Acetate delivered with a Hemostatic Matrix Kit prior to closure.

Intervention: Methylprednisolone Acetate

Treatment

Procedure: Anterior Cervical Discectomy and Fusion. The treatment arm will receive 40 mg of Methylprednisolone Acetate delivered with a Hemostatic Matrix Kit prior to closure.

Intervention: Hemostatic Matrix Kit

Control

Procedure: Anterior Cervical Discectomy and Fusion. The control group will receive only a Hemostatic Matrix Kit prior to closure.

Intervention: Hemostatic Matrix Kit

Outcomes

Primary Outcomes

Degree of Dysphagia Patients Experience (Social)

Time Frame: Post-Op Day 1, Post-Op Day 2, Week 4-6, 3 Months, 6 Months, 12 Months

SWAL-QOL survey - Social domain Score ranges between 0 and 100 (worst-best)

Degree of Dysphagia Patients Experience (Burden)

Time Frame: Post-Op Day 1, Post-Op Day 2, Week 4-6, 3 Months, 6 Months, 12 Months

SWAL-QOL survey - Burden domain Score ranges between 0 and 100 (worst-best)

Degree of Dysphagia Patients Experience (Eating Desire)

Time Frame: Post-Op Day 1, Post-Op Day 2, Week 4-6, 3 Months, 6 Months, 12 Months

SWAL-QOL survey - Eating desire domain Score ranges between 0 and 100 (worst-best)

Degree of Dysphagia Patients Experience (Sleep)

Time Frame: Post-Op Day 1, Post-Op Day 2, Week 4-6, 3 Months, 6 Months, 12 Months

SWAL-QOL survey - Sleep domain Score ranges between 0 and 100 (worst-best)

Degree of Dysphagia Patients Experience (Food Selection)

Time Frame: Post-Op Day 1, Post-Op Day 2, Week 4-6, 3 Months, 6 Months, 12 Months

SWAL-QOL survey - Food Selection domain Score ranges between 0 and 100 (worst-best)

Degree of Dysphagia Patients Experience (Eating Duration)

Time Frame: Post-Op Day 1, Post-Op Day 2, Week 4-6, 3 Months, 6 Months, 12 Months

SWAL-QOL survey - Eating duration domain Score ranges between 0 and 100 (worst-best)

Degree of Dysphagia Patients Experience (Fear Swallow)

Time Frame: Post-Op Day 1, Post-Op Day 2, Week 4-6, 3 Months, 6 Months, 12 Months

SWAL-QOL survey - Fear swallow domain Score ranges between 0 and 100 (worst-best)

Degree of Dysphagia Patients Experience (Communication)

Time Frame: Post-Op Day 1, Post-Op Day 2, Week 4-6, 3 Months, 6 Months, 12 Months

SWAL-QOL survey - Communication domain Score ranges between 0 and 100 (worst-best)

Degree of Dysphagia Patients Experience (Mental)

Time Frame: Post-Op Day 1, Post-Op Day 2, Week 4-6, 3 Months, 6 Months, 12 Months

SWAL-QOL survey - Mental domain Score ranges between 0 and 100 (worst-best)

Degree of Dysphagia Patients Experience (Fatigue)

Time Frame: Post-Op Day 1, Post-Op Day 2, Week 4-6, 3 Months, 6 Months, 12 Months

SWAL-QOL survey - Fatigue domain Score ranges between 0 and 100 (worst-best)

Secondary Outcomes

  • Patient Reported Swallowing Difficulty Over 1 Year(Pre-Op, Post-Op Day 1, Post-Op Day 2, Week 4-6, 3 Months, 6 Months, 12 Months)
  • Patients' Bazaz Dysphagia Score - Solid(Pre-Op, Post-Op Day 1, Post-Op Day 2, Week 4-6, 3 Months, 6 Months, 12 Months)
  • Patients' Neck Disability(Pre-Op, Week 4-6, 3 Months, 6 Months, 12 Months)
  • Fusion Rate(12 Months)
  • Patients' Pain Scores on the Visual Analog Scale - Left Arm Pain(Pre-Op, Post-Op Day 1, Post-Op Day 2, Week 4-6, 3 Months, 6 Months, 12 Months)
  • Patients' Bazaz Dysphagia Score - Liquid(Pre-Op, Post-Op Day 1, Post-Op Day 2, Week 4-6, 3 Months, 6 Months, 12 Months)
  • Patients' Pain Scores on the Visual Analog Scale - Neck Pain(Pre-Op, Post-Op Day 1, Post-Op Day 2, Week 4-6, 3 Months, 6 Months, 12 Months)
  • Patients' Pain Scores on the Visual Analog Scale - Right Arm Pain(Pre-Op, Post-Op Day 1, Post-Op Day 2, Week 4-6, 3 Months, 6 Months, 12 Months)
  • Change in Pre-vertebral Soft Tissue Swelling Over 1 Year(Pre-Op, Post-Op Day 1, Week 4-6, 3 Months, 6 Months, 12 Months)
  • Adverse Event(12 month)

Similar Trials